Incannex Healthcare Limited (IXHL)

Healthcare | Drug Manufacturers Specialty Generic
Income Statement (Quarterly) 2024-12-31 2024-06-30 2024-03-31 2023-12-31
Revenue 12,000 12,000 0 0
Cost of Revenue 0 0 0 0
Gross Profit 12,000 12,000 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 3,602,000 5,294,000 4,138,000 5,345,000
Operating Expenses 5,016,000 9,756,000 7,415,000 7,983,000
Operating Income -5,004,000 -9,744,000 -7,415,000 -7,983,000
Interest Expense 171,000 0 0 0
Income Before Tax -5,894,000 -6,431,000 -6,031,000 -5,241,000
Income Tax Expense 0 30,000 0 0
Net Income -5,894,000 -6,461,000 -6,031,000 -5,241,000
Per Share
EPS -0.33 -0.38 -0.38 -0.33
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Revenue 86,000 12,000 0 0 1,897,596
Cost of Revenue 0 0 88,080 6,338 911,968
Gross Profit 86,000 12,000 0 -6,338 985,628
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 13,128,000 17,071,000 7,924,000 10,179,778 3,248,207
Operating Expenses 23,875,000 30,053,000 13,638,000 14,769,216 9,224,965
Operating Income -23,789,000 -30,041,000 -49,668,000 -14,775,554 -8,239,337
Interest Expense 303,000 0 3,013 6,271 0
Income Before Tax -46,885,000 -18,429,000 -48,811,000 -14,903,909 -8,163,590
Income Tax Expense 0 30,000 0 122,084 0
Net Income -46,885,000 -18,459,000 -48,811,000 -15,025,993 -8,163,590
Per Share
EPS -1.36 -1.14 -3.17 -0.32 -0.17
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Assets
Cash and Cash Equivalents 15,039,000 5,858,000 22,084,176 25,797,239
Short Term Investments 0 0 0 0
Net Receivables 4,626,000 10,015,000 256,489 219,333
Inventory 0 0 -416,160 0
Total Current Assets 19,962,000 16,202,000 22,959,686 26,057,734
Property Plant Equipment 485,000 845,000 785,968 0
Goodwill and Intangibles 0 0 34,895,333 0
Total Assets 20,447,000 17,047,000 58,640,988 26,057,734
Liabilities
Account Payables 6,074,000 527,000 1,792,140 894,760
Short Term Debt 184,000 163,000 112,962 0
Total Current Liabilities 6,984,000 5,620,000 2,545,620 1,383,064
Long Term Debt 74,000 210,000 407,807 0
Total Liabilities 7,058,000 5,830,000 2,953,428 1,383,064
Shareholders Equity
Retained Earnings -157,556,000 -110,671,000 -52,143,313 -40,445,566
Total Shareholders Equity 13,389,000 11,217,000 55,687,559 24,674,670
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Assets
Cash and Cash Equivalents 15,039,000 5,858,000 22,084,176 25,797,239 9,123,617
Short Term Investments 0 0 0 0 0
Net Receivables 4,626,000 10,015,000 256,489 219,333 169,088
Inventory 0 0 -416,160 0 0
Total Current Assets 19,962,000 16,202,000 22,959,686 26,057,734 9,328,795
Property Plant Equipment 485,000 845,000 785,968 0 0
Goodwill and Intangibles 0 0 34,895,333 0 0
Total Assets 20,447,000 17,047,000 58,640,988 26,057,734 9,328,795
Liabilities
Account Payables 6,074,000 527,000 1,792,140 894,760 233,117
Short Term Debt 184,000 163,000 112,962 0 0
Total Current Liabilities 6,984,000 5,620,000 2,545,620 1,383,064 755,049
Long Term Debt 74,000 210,000 407,807 0 0
Total Liabilities 7,058,000 5,830,000 2,953,428 1,383,064 755,049
Shareholders Equity
Retained Earnings -157,556,000 -110,671,000 -52,143,313 -40,445,566 -40,681,793
Total Shareholders Equity 13,389,000 11,217,000 55,687,559 24,674,670 8,573,746
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Activities
Net Income -46,885,000 -18,459,000 -13,225,102 -10,252,538
Depreciation & Amortization 246,000 103,000 86,677 0
Stock Based Compensation 2,609,000 8,928,000 3,191,640 1,007,477
Change in Working Capital 6,775,000 -9,468,000 476,971 843,638
Operating Cash Flow -12,513,000 -15,845,000 -10,553,060 -8,810,311
Investing Activities
Capital Expenditure -8,000 -277,000 -315,657 0
Investments -8,000 -277,000 -315,657 0
Investing Cash Flow -8,000 -277,000 -315,657 29,277
Financing Activities
Debt Repayment -1,306,000 0 -36,219 0
Common Stock Issued/Repurchased 47,471,000 0 8,161,805 28,331,329
Dividends Paid 0 0 0 0
Financing Cash Flow 21,396,000 0 8,125,586 28,331,329
Summary
Free Cash Flow -12,521,000 -16,122,000 -10,868,718 -8,810,311
Net Change in Cash 9,181,000 -16,262,000 -2,738,877 19,521,018
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Operating Activities
Net Income -46,885,000 -18,459,000 -13,225,102 -10,252,538 -8,163,590
Depreciation & Amortization 246,000 103,000 86,677 0 0
Stock Based Compensation 2,609,000 8,928,000 3,191,640 1,007,477 0
Change in Working Capital 6,775,000 -9,468,000 476,971 843,638 0
Operating Cash Flow -12,513,000 -15,845,000 -10,553,060 -8,810,311 0
Investing Activities
Capital Expenditure -8,000 -277,000 -315,657 0 0
Investments -8,000 -277,000 -315,657 0 0
Investing Cash Flow -8,000 -277,000 -315,657 29,277 29,277
Financing Activities
Debt Repayment -1,306,000 0 -36,219 0 0
Common Stock Issued/Repurchased 47,471,000 0 8,161,805 28,331,329 12,401,230
Dividends Paid 0 0 0 0 0
Financing Cash Flow 21,396,000 0 8,125,586 28,331,329 12,401,230
Summary
Free Cash Flow -12,521,000 -16,122,000 -10,868,718 -8,810,311 -6,910,280
Net Change in Cash 9,181,000 -16,262,000 -2,738,877 19,521,018 5,520,227